Samsara BioCapital as of Sept. 30, 2022
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 55 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chinook Therapeutics | 23.7 | $102M | 5.2M | 19.66 | |
| Nkarta (NKTX) | 8.8 | $38M | 2.9M | 13.16 | |
| Scholar Rock Hldg Corp (SRRK) | 7.4 | $32M | 4.6M | 6.93 | |
| Graphite Bio | 6.3 | $27M | 8.5M | 3.17 | |
| Forma Therapeutics Hldgs SHS | 5.0 | $21M | 1.1M | 19.95 | |
| Arcellx Common Stock (ACLX) | 4.7 | $20M | 1.1M | 18.77 | |
| Iveric Bio | 3.4 | $15M | 808k | 17.94 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $11M | 696k | 15.74 | |
| Hillevax | 2.4 | $10M | 610k | 17.09 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.2 | $9.6M | 939k | 10.22 | |
| Sutro Biopharma (STRO) | 2.2 | $9.3M | 1.7M | 5.55 | |
| Intercept Pharmaceuticals In | 2.1 | $8.9M | 641k | 13.95 | |
| Lyra Therapeutics | 2.1 | $8.9M | 1.8M | 5.01 | |
| Instil Bio | 2.0 | $8.7M | 1.8M | 4.84 | |
| Rhythm Pharmaceuticals (RYTM) | 2.0 | $8.5M | 345k | 24.50 | |
| Rain Therapeutics | 1.8 | $7.6M | 1.6M | 4.88 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.6 | $6.8M | 1.7M | 4.02 | |
| Zymeworks | 1.4 | $6.0M | 971k | 6.15 | |
| Pepgen (PEPG) | 1.4 | $5.9M | 651k | 9.08 | |
| Syros Pharmaceuticals | 1.3 | $5.7M | 882k | 6.44 | |
| Dice Therapeutics | 1.2 | $5.1M | 254k | 20.28 | |
| Jiya Acquisition Corp Com Cl A | 1.2 | $5.1M | 507k | 9.97 | |
| Janux Therapeutics (JANX) | 1.1 | $4.9M | 360k | 13.54 | |
| Day One Biopharmaceuticals I (DAWN) | 0.9 | $3.9M | 196k | 20.03 | |
| Immunocore Hldgs Ads (IMCR) | 0.9 | $3.8M | 81k | 46.94 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.9 | $3.8M | 480k | 7.91 | |
| Igm Biosciences (IGMS) | 0.8 | $3.5M | 155k | 22.74 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.8 | $3.3M | 659k | 5.01 | |
| Bcls Acquisition Corp Com Cl A | 0.7 | $3.0M | 300k | 10.02 | |
| Viracta Therapeutics (VIRX) | 0.7 | $2.9M | 690k | 4.27 | |
| Decibel Therapeutics | 0.6 | $2.8M | 802k | 3.46 | |
| Io Biotech (IOBT) | 0.6 | $2.7M | 1.0M | 2.71 | |
| Alx Oncology Hldgs (ALXO) | 0.6 | $2.5M | 263k | 9.57 | |
| Tango Therapeutics (TNGX) | 0.5 | $2.3M | 630k | 3.62 | |
| Amryt Pharma Sponsored Ads | 0.5 | $2.1M | 305k | 6.92 | |
| Albireo Pharma | 0.5 | $1.9M | 100k | 19.36 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $1.7M | 289k | 5.89 | |
| Vtv Therapeutics Cl A | 0.4 | $1.6M | 1.6M | 0.97 | |
| Bolt Biotherapeutics | 0.4 | $1.6M | 1.0M | 1.48 | |
| Science 37 Holdings | 0.3 | $1.4M | 900k | 1.61 | |
| Equillium (EQ) | 0.3 | $1.4M | 616k | 2.22 | |
| Allakos | 0.2 | $1.1M | 172k | 6.12 | |
| Elevation Oncology (ELEV) | 0.2 | $939k | 831k | 1.13 | |
| Novavax Com New (NVAX) | 0.2 | $813k | 45k | 18.22 | |
| Allovir (ALVR) | 0.2 | $650k | 82k | 7.89 | |
| Springworks Therapeutics (SWTX) | 0.1 | $633k | 22k | 28.51 | |
| Atreca Cl A Com (BCEL) | 0.1 | $623k | 397k | 1.57 | |
| Surrozen | 0.1 | $606k | 300k | 2.02 | |
| Aeglea Biotherapeutics | 0.1 | $465k | 884k | 0.53 | |
| Kronos Bio | 0.1 | $262k | 78k | 3.35 | |
| Astria Therapeutics (ATXS) | 0.1 | $226k | 25k | 9.04 | |
| Ngm Biopharmaceuticals | 0.0 | $179k | 14k | 13.10 | |
| Kala Pharmaceuticals | 0.0 | $132k | 601k | 0.22 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $27k | 133k | 0.20 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $18k | 100k | 0.18 |
